期刊文献+

玉泉丸对盐酸二甲双胍在糖尿病大鼠体内药动学的影响 被引量:6

Effects of Yuquan pills on pharmacokinetics of metformin hydrochloride in diabetic rats
下载PDF
导出
摘要 目的:研究玉泉丸对盐酸二甲双胍在糖尿病大鼠体内药动学过程的影响。方法:糖尿病模型大鼠灌胃给予玉泉丸7 d后,给予盐酸二甲双胍,给药后于不同时间采集血样,用高效液相色谱方法测定血药浓度,计算药动学参数。结果:二甲双胍组、联合用药组的药动学参数Cmax分别是18.95,21.76 mg.L-1;t1/2分别是1 069.8,1 767.4 min;CL/F分别是0.013,0.008 L.min-1.kg-1;AUC分别是10 042.1,10 712.2 mg.L-1.min-1。结论:盐酸二甲双胍在糖尿病大鼠体内药动学过程符合一室模型,玉泉丸对盐酸二甲双胍在糖尿病大鼠体内的药动学有显著影响。 Objective: To study effects of Yuquan pills on the pharmacokinetics process of mefformin hydrochloride in diabetic rats. Method: After administration Yuquan pills 7 day to the diabetic rats, the metformin hydrochloride was orally administrated, then the blood samples were collected at different time. The concentrations of mefformin hydrochloride in plasma were determined by HPLC method and the pharmacokinetic parameters were calculated. Result: The pharmacokinetie parameter Cmax of the controlling group and the testing group were respectively, 18. 95, 21.76 mg·L^-1 ; t/2 were 1 069. 8, 1 767.4 rain, respectively; CL/F were 0. 013, 0. 008 L ·min^-1· kg-1 ; AUC were 10 042. 1, 10 712. 2 mg · L^-1 . min-1 respectively. Conclusion: The pharmacokineties process of metformin hydrochloride in diabetic rats fits one-compartment model. Yuquan pills has a significant effect on the pharmacokinetics of metformin hydrochloride in diabetic rats.
出处 《中国中药杂志》 CAS CSCD 北大核心 2008年第18期2133-2135,2139,共4页 China Journal of Chinese Materia Medica
基金 甘肃省中医药管理局资助项目(GZK-2007-36)
关键词 玉泉丸 盐酸二甲双胍 糖尿病大鼠模型 药动学 Yuquan pills metformin hydrochloride diabetic rats model pharmacokinetics
  • 相关文献

参考文献12

二级参考文献24

  • 1李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:253
  • 2Haffner SM,D,Agostino R,Mykkanen L.Insulin sensitivity in subject with type 2 diabetes.Diabetes Care,1999,22:256-268. 被引量:1
  • 3Muller G,Hartz D,Punter J.et al.Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor I binding chatacteristics.Biochim Biophys Acta,1994,1191:267-277. 被引量:1
  • 4Kobayashi M,Kaku K,Kawamori R,et al.Glimepiride improves HbAlc without weight gain in obese Japanese type 2 diabetic patients.Diabetes,2003,52(1):A97. 被引量:1
  • 5Martin S,Scherbaum WA,Kolb W.Analysis of the impact of oral anti-diabetic drugs on development of body weight by a retrolective trial,a new form of non-biased retrospective clinical study design.Diabetes,2002,51(2):A107.Abstract 433. 被引量:1
  • 6Korytkowski M,Thomas A,Reid L,et al.Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes.Diabetes Care,2002,25(9):1607-1611 被引量:1
  • 7Singh J,Unnikrishnan AG,Agrawal NK.Immunoreactive insulin response to a single dose of glimepiride in lean type 2 diabetic subjects.J Assoc Physicians India,2002,50:1232-1235. 被引量:1
  • 8Muller G,Jung C,Wied S,et al.Linsulin-mimetie signaling by the sulfonylurea glimepiride phospoinoislolglycans involves distinct mechanisms for redistribution of lipid raft components.Biochemistry,2001,40(48):14603-14620. 被引量:1
  • 9Tsunekawa T,Hayashi T,Suzuki Y,et al.Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects.Diabetes Care,2003,26(2):285-289. 被引量:1
  • 10Nagasaka S,Taniguchi A,Aiso Y,et al.Effect of glimepiride on serum adiponectin level in subjects with type 2 dDiabetes.Diabetes Care,2003,26(7):2215-2216. 被引量:1

共引文献31

同被引文献1977

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部